China Medical Technologies Reports First Quarter Financi...(1569) (206) Amortization ...)

Amortization

of convertible

notes issuance

cost -- (2,064) (2,043) (268)

Income before

tax 50,524 92,919 59,618 7,832

Income tax

expense (4,606) (9,194) (7,927) (1,041)

Net income 45,918 83,725 51,691 6,791

Earnings per

ADS - basic 1.68 3.20 1.97 0.26

- diluted (2) 1.68 3.11 1.96 0.26

Weighted

average

number of

ADS

- basic 27,360,000 26,196,308 26,196,308 26,196,308

- diluted(2) 27,385,701 30,882,901 26,317,214 26,317,214

Notes:

(1) Revenues, net

- ECLIA 42,810 65,879 79,051 10,385

- FISH -- -- 14,442 1,897

- HIFU 48,138 97,224 57,997 7,619

90,948 163,103 151,490 19,901

(2) In computing diluted EPS for the three months ended March 31, 2007,

interest expense and amortization in connection with convertible notes

were added back to net income before dividing by the diluted number of

ADS because potential shares from the conversion of convertible notes

were included. For the three months ended June 30, 2007, the total

number of potential shares to be converted pursuant to the conversion

of convertible notes was not included in the computation of diluted

EPS because to do so would have been anti-dilutive.

China Medical Technologies, Inc.

Reconciliations of Non-GAAP Adjusted Net Income to GAAP Net Income

'/>"/>